Company / Operating Cash Flow per Share
LEXICON PHARMACEUTICALS, INC. Operating Cash Flow per Share History
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.45
FY2025
5-year range
-$1.69 / -$0.45
FY2021-FY2025
Trend
+16.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has increased for 4 consecutive years, from $-1.69 in FY2018 to $-0.45 in FY2025.
Based on SEC 10-K filings.
-0.45 in FY2025.
Improved from $-0.60 to $-0.45 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- LEXICON PHARMACEUTICALS, INC.'s operating cash flow per share has grown for 4 consecutive years.
- In FY2025, operating cash flow per share increased 16.8% year-over-year.
- Peak operating cash flow per share was recorded in FY2017.
- Lowest operating cash flow per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -1.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.45 | +16.8% |
| FY2024 | -$0.54 | +10.3% |
| FY2023 | -$0.60 | +55.8% |
| FY2019 | -$1.35 | +20.0% |
| FY2018 | -$1.69 | -194.8% |
| FY2017 | $1.78 | +280.1% |
| FY2016 | -$0.99 | +20.3% |
| FY2015 | -$1.24 | -544.2% |
| FY2014 | -$0.19 | +25.3% |
| FY2013 | -$0.26 | +5.1% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026